Ghost Tree Capital as of Sept. 30, 2019
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 42 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sarepta Therapeutics (SRPT) | 8.1 | $32M | 420k | 75.32 | |
| SPDR S&P Biotech (XBI) | 7.8 | $31M | 401k | 76.25 | |
| Spdr S&p 500 Etf (SPY) | 7.6 | $30M | 100k | 296.77 | |
| Immunomedics | 6.5 | $26M | 1.9M | 13.26 | |
| Blueprint Medicines (BPMC) | 6.1 | $24M | 325k | 73.47 | |
| Mirati Therapeutics | 5.5 | $21M | 275k | 77.91 | |
| Sage Therapeutics (SAGE) | 3.9 | $15M | 110k | 140.29 | |
| Biohaven Pharmaceutical Holding | 3.7 | $15M | 350k | 41.72 | |
| Ascendis Pharma A S (ASND) | 3.7 | $14M | 150k | 96.32 | |
| Invesco Qqq Trust Series 1 (QQQ) | 3.6 | $14M | 75k | 188.81 | |
| Amicus Therapeutics (FOLD) | 3.5 | $14M | 1.7M | 8.02 | |
| Axsome Therapeutics (AXSM) | 3.5 | $14M | 675k | 20.24 | |
| Invesco Currencyshares British Pound Sterling Trust etf (FXB) | 3.2 | $13M | 106k | 119.25 | |
| BioMarin Pharmaceutical (BMRN) | 3.2 | $13M | 185k | 67.40 | |
| Pacira Pharmaceuticals (PCRX) | 2.4 | $9.5M | 250k | 38.07 | |
| Iovance Biotherapeutics (IOVA) | 2.3 | $9.1M | 500k | 18.20 | |
| Adverum Biotechnologies | 2.0 | $7.9M | 1.5M | 5.45 | |
| Rocket Pharmaceuticals (RCKT) | 1.9 | $7.3M | 625k | 11.65 | |
| Athenex | 1.6 | $6.4M | 523k | 12.16 | |
| Argenx Se (ARGX) | 1.4 | $5.7M | 50k | 113.96 | |
| Fate Therapeutics (FATE) | 1.4 | $5.4M | 350k | 15.53 | |
| Turning Point Therapeutics I | 1.2 | $4.7M | 125k | 37.60 | |
| Momenta Pharmaceuticals | 1.2 | $4.5M | 350k | 12.96 | |
| Kadmon Hldgs | 1.1 | $4.4M | 1.8M | 2.52 | |
| Invesco exchange traded (FXF) | 1.1 | $4.4M | 48k | 92.61 | |
| Milestone Pharmaceuticals (MIST) | 1.1 | $4.4M | 235k | 18.65 | |
| BioCryst Pharmaceuticals (BCRX) | 1.1 | $4.3M | 1.5M | 2.87 | |
| Aerie Pharmaceuticals | 1.1 | $4.3M | 225k | 19.22 | |
| Homology Medicines | 1.0 | $4.1M | 225k | 18.10 | |
| Reata Pharmaceuticals Inc Cl A | 1.0 | $4.0M | 50k | 80.30 | |
| Arvinas Ord (ARVN) | 1.0 | $4.0M | 185k | 21.55 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $3.7M | 315k | 11.60 | |
| Dicerna Pharmaceuticals | 0.9 | $3.4M | 235k | 14.36 | |
| Protagonist Therapeutics (PTGX) | 0.8 | $3.0M | 250k | 12.01 | |
| Orchard Therapeutics Plc ads | 0.7 | $2.9M | 243k | 11.88 | |
| Viewray (VRAYQ) | 0.6 | $2.4M | 825k | 2.90 | |
| Cymabay Therapeutics | 0.6 | $2.3M | 440k | 5.12 | |
| Avrobio Ord (AVRO) | 0.6 | $2.2M | 155k | 14.12 | |
| Chiasma | 0.5 | $1.9M | 383k | 4.95 | |
| Epizyme | 0.3 | $1.4M | 132k | 10.32 | |
| Solid Biosciences | 0.3 | $1.0M | 100k | 10.34 | |
| Dermira | 0.1 | $272k | 43k | 6.40 |
